Movement disorders Dr.Zana A. Mohammed M.B.Ch.B, F.I.B.M.S. NEUROLOGY

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Evaluation of Movement Disorders
Leslie Cloud, MD Department of Neurology Division of Movement Disorders Emory University School of Medicine.
Cortically OriginatedMovement Cortically Originated Movement I. Motor Tract (corticospinal tractus) Extrapyramidal System (basal ganglia) Cerebellum Praxis.
Parkinson’s Disease (PD)
The PARticulars of Parkinson’s Disease
Parkinson’s Disease Dr Rachel Cary, Warwick Hospital.
Idiopathic parkinson’s disease (IPD)
Drugs Used to Treat Parkinson’s Disease By Jasmine and Morgan 11/13/03.
EXTRAPYRAMIDAL SYSTEM DISORDERS BASAL GANGLION DYSFUNCTION BASAL GANGLION DYSFUNCTION.
Parkinson’s Disease Historical Perspective  First described by British doctor James Parkinson  Identified its major symptoms and called it “the shaking.
Paul Short, Ph.D. The Parkinson’s Coach NEUROPSYCHOLOGY OF PARKINSON’S COMMUNICATION PROBLEMS.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Prepared by: Muhammad Ibrahim khan BS.PT(Pak), MS.PT(Pak), NCC(AKUH), CHPE(KMU)
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Basal ganglia & cerebellar pathology
Erica Partridge Parkinson’s Disease. Definition Aetiology PD vs Parkinsonism Symptoms and signs Differentials Investigations Management Prognosis.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
Pyramidal and extrapyramidal tracts
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Parkinson’s Disease By Devin Cornford
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 14 Antiparkinsonian Drugs.
Neurological Manifestations of Wilson’s Disease Aleksandar Videnovic, MD, MSc Assistant Professor of Neurology Feinberg School of Medicine Northwestern.
Parkinson’s Disease. Definition Parkinson's disease (PD) is an idiopathic, slowly progressive, neurodegenerative disorder whereby two or more of the following.
Parkinson’s Disease superKAT :).
Neuroscience 1 Pause for thought: Probably 100 million neurones fire during skilled movements.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
PhD MD MBBS Faculty of Medicine Al Maarefa Colleges of Science & Technology Faculty of Medicine Al Maarefa Colleges of Science & Technology Lecture – 9:
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Mostly Parkinson’s disease but also few other movement disorders due to diseases of the basal ganglia.
BASAL GANGLIA Basal ganglia are subcorticle nuclei of grey matter located in the interior part of cerebrum near about base 3.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
 Parkinson’s Disease (PD) -progressive neurodegenerative disease affecting motor ability -third most common neurologic disorder of older adults.
Neurological Disorders
second most common neurodegenerative disorder progressive loss of muscle control trembling of the limbs and head while at rest stiffness, slowness, and.
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
PARKINSON’S DISEASE.
The Substantia Nigra THE BRAIN Symptoms differ from every person suffering from the disease. There are two types of symptoms, primary, secondary.
Extrapyramidal pathway
PARKINSON’S DISEASE Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine.
CNS -Antiparkinsonian Drugs Discuss the signs and symptoms exhibited by a patient with Parkinson’s Disease Describe the actions and intended effects of.
Neurotransmitters in the brain By Joon Kim. Neurotransmitters  A neurotransmitter is a specialized messenger chemical that transfers or sends information.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Pharmacological Treatment of Parkinson Disease: A.
Parkinson’s Disease By: Taylor Hawkins, Ana McGhee, and Morgan Zander.
Parkinson's disease ♦ Is a neurodegenerative disorder ♦ Develops around age 50 * incidence rises with age * affects 1-2% of population > age 65 ♦ Higher.
Direct motor pathway Corticospinal pathway. Motor Units – Large Versus Small Text Fig
 DEFINITION: It includes all fibers that can influence the motor end plate activity and do not pass in the pyramidal tract.
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Direct motor pathway Corticospinal pathway.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
Parkinson’s Disease.
Parkinson Disease Parkinson disease is an idiopathic, slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity),
MOVEMENT DISORDERS.
Drugs of Anti-Parkinson’s disease
Parkinson's disease KRZYSZTOF NICPOŃ.
EXTRAPYRAMIDAL SYSTEM DISORDERS
Treatment of Parkinson’s disease
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Parkinson’s disease.
Parkinson's disease Parkinson's disease (PD) is the second-most common
Long Term Effects of Concussions
The Approach to Tremor (with case examples) Praveen Dayalu MD Associate Professor Department of Neurology University of Michigan.
Basal ganglia function
Drugs for Degenerative Diseases of the Nervous System
Classification of Epilepsy (p. 227)
Neurodegenerative diseases
HOW DOES EXPERIENCE AFFECT BEHAVIOUR AND MENTAL PROCESSES?
Presentation transcript:

Movement disorders Dr.Zana A. Mohammed M.B.Ch.B, F.I.B.M.S. NEUROLOGY SCHOOL OF MEDICINE UNIVERSITY OF SULAIMANIAH

Essential tremor Essential tremor, the most common movement disorder, is a syndrome of unknown etiology characterized by a slowly progressive postural and/or kinetic tremor, usually affecting both upper extremities. Essential tremor is familial in at least 50-70% of cases. Transmission is AD, with incomplete penetrance. Some cases are sporadic with unknown etiology.

Clinical presentation Essential tremor generally is considered to be monosymptomatic (tremor only), although some patients have abnormalities in gait and balance. The tremor is characteristically postural (occurring with voluntary maintenance of a position against gravity) and kinetic (occurring during voluntary movement). A family history of essential tremor is noted in 50-70% of cases

Tremor usually begins in one upper extremity and soon affects the other; essential tremor rarely extends from the upper extremity to the ipsilateral leg A mild degree of asymmetry is not unusual In about 30% of cases, tremor involves the cranial musculature; the head is involved most frequently, followed by voice, jaw, and face

The amplitude of the tremor is highly variable, depending on the state of emotional activation; tremor amplitude is worsened by emotion, hunger, fatigue, and temperature extremes A degree of voluntary control is typical, and the tremor may be suppressed by skilled manual tasks

Tremor may be intermittent initially, emerging only during periods of emotional activation Over time the tremor becomes persistent The tremor resolves during sleep Ethanol intake temporarily reduces tremor amplitude in an estimated 50-70% of cases It usually resolves when the body part relaxes.

Other characteristics of essential tremor include the following: Both upper extremities are typically affected Mild asymmetry is not uncommon Tremor also may affect the head, voice, and lips Tone and reflexes are normal Parkinsonian features such as bradykinesia and rigidity are absent

Diagnosis Essential tremor is usually diagnosed based on family history and examination findings; thus, laboratory and imaging studies are usually not required. Head (CT) scanning and magnetic (MRI) findings are normal in essential tremor.

If the patient’s family history and examination findings are not indicative of essential tremor, consider the following laboratory studies: Standard electrolyte panel Thyroid function tests Blood urea nitrogen and creatinine levels Liver function tests Serum ceruloplasmin (for Wilson disease)

Treatment Primidone and propranolol are the cornerstones of maintenance medical therapy for essential tremor. These reduce tremor amplitude in approximately 50-70% of patients. Some patients require only intermittent tremor reduction (eg, to attend a meeting or engage in a social activity). they may take propranolol (10-40 mg) approximately one half hour prior to the event.

Parkinson’s disease Parkinsonism is a progressive degenerative, extra pyramidal disorder of muscle movement, due to dysfunction in basal ganglia, comprising four cardinal features:- Brady kinesia or hypo kinesia. Muscle rigidity. Resting tremor. Impairment of postural balance leading to disturbances of gait, and falling. The secondary manifestations are mask-like face, difficulty in speech, slowing of mental process and dementia.

PD – Impairment of Postural Balance Prone to falling

Parkinsonism (PD) - signs

The classical syndrome: Tremors Rigidity Bradykinesia These may be absent initially, when non-specific symptoms of tiredness, aching limbs, mental slowness, depression & small handwriting (micrographia) may be noticed. Although parkinsonian features are initially unilateral, gradual bilateral involvement is the rule. A resting tremor in an upper limb being a common presenting feature.

Tremor Resting 4-6 Hz Postural 8-10 Hz Resting tremor, may remain the predominant symptom for some years. i with activity, h tremor when… Walking Anxious Resting 4-6 Hz Usually first in fingers/thumb, may also affect the legs, mouth & tongue. Coarse, complex movements, flexion/extension of fingers Abduction/adduction of thumb Supination/pronation of forearm May affect arms, legs, feet, jaw, tongue Intermittent, present at rest & when distracted Diminished on action Postural 8-10 Hz Less obvious, faster, finer amplitude Present on action or posture, persists with movement

Rigidity Stiffness Neck Trunk Shoulders Posture Head bowed Cogwheel type, mostly upper limbs -Rigidity with superimposed tremor, felt as tigthness/stiffness of muscles, Ratchet-like (catch-release-catch release like movement. Plastic (lead pipe) type, mostly legs Stiffness Neck Trunk Shoulders Posture Head bowed Body bent forward Arms flexed Thumbs turned into palms Knees bent (slightly)

Bradykinesia Slowed ability to start and continue movements, and impaired ability to adjust the body's position. The word bradykinesia is = slow movement Akinesia =Loss of movement Especially face Expressionless face(poker/masked-face) Slow speech-softer & indistinct Dysphonia Dysphagia Drooling Slowness in initiating or repeating movements -Most have difficulty with rapid fine movements, as slowness of gait &difficulty with tasks as fastening buttons, shaving or writing (micrographia).

Abnormal Gait/posture Asymmetrical Gait Slow to start walking Shortened stride Stiff legged gait-rigidity comes through on one side, therefore difficult clearing swinging on one side Rapid, small steps, tendency to run (festination) Reduced arm swing (usually unilateral) Impaired balance on turning Leads with head and shoulders Fall forward down turned posture-Postural righting reflexes are impaired early, but falls tend not to occur until later.

Additional features Muscle strength / reflexes remain normal, plantar responses are flexor. There is a paucity of facial expression (hypomimia) & the blink reflex may be exaggerated & fail to habituate (glabellar tap sign). Sensation is normal & intellectual abilities are not affected initially. As the disease progresses, 1/3 develop cognitive impairment. PD commonly associated with other features; loss of smell, depression, dementia, autonomic dysfunction, sleep disturbance- due to involvement of other non-dopaminergic structures as disease progresses.

Etiology The degeneration of neurons occurs in substantia nigra pars compacta and the nigrostriatal tract that are dopaminergic and inhibit the activity of striatal GABA ergic neurons. This results in deficiency of dopamine in striatum which controls muscle tone and coordinates movements. Nerve fibers from cerebral cortex and thalamus secrete acetylcholine in the neostriatum causing excitatory effects that initiate and regulate gross intentional movements of the body. In Parkinson’s disease, due to deficiency of dopamine in striatum, an imbalance between dopaminergic (inhibitory) and cholinergic (excitatory) system occurs, leading to excessive excitatory actions of cholinergic neurons on striatal GABA ergic neurons.

Pathophysiology Degeneration of neurons in the substantia nigra pars compacta Degeneration of nigrostriatal (dopaminergic) tract Results in deficiency of Dopamine in Striatum - >80%

Pathophysiology Imbalance primarily between the excitatory neurotransmitter Acetylcholine and inhibitory neurotransmitter Dopamine in the Basal Ganglia DA ACh

Salvador Dali- Spanish artist Strategy of Treatment In Parkinson’s disease dopaminergic inhibitory activity is reduced and cholinergic excitatory activity is increased. Therefore, therapy is aimed at restoring dopamine in the basal ganglia and antagonizing the excitatory effects of cholinergic neurons. Salvador Dali- Spanish artist

Treatment of PD

Drugs used for Parkinsonian Disease: Drug therapy is aimed at restoring the balance between the dopaminergic and cholinergic components, which is achieved by: Increasing the central dopaminergic activity OR Decreasing the central cholinergic activity OR BOTH. Hitler and Franco

Drugs which increase dopaminergic activity. Drugs that replace dopamine (Dopamine precursor): Levodopa Dopa-decarboxylase inhibitors (Drugs which increase the central availability of Levodopa) Carbidopa, Benserazide. They act in the periphery as they do not enter brain . Lahore Medical & Dental College

Dopamine agonist like bromocriptine and pramipexol Drugs which increase release or inhibit reuptake of dopamine (also called dopamine facilitator) like Amantadine. MAO-B inhibitor (selegnine) prevent dopamine breakdown

(for your patience) Thank you